JP Morgan Chase
IDNA icon

JP Morgan Chase’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

JP Morgan Chase’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-583
Closed -$14.3K – 7549
2024
Q3 		$14.3K Sell
583
-1,381
-70% -$33.7K ﹤0.01% 6306
2024
Q2 		$45.4K Buy
1,964
+1,624
+478% +$38K ﹤0.01% 5898
2024
Q1 		$8.19K Buy
+340
New +$7.97K ﹤0.01% 6370
2023
Q4 		– Sell
-20
Closed -$407 – 7675
2023
Q3 		$407 Buy
+20
New +$449 ﹤0.01% 6752
2023
Q2 		– Sell
-19
Closed -$15 – 7103
2023
Q1 		$15 Sell
19
-27
-59% -$675 ﹤0.01% 6631
2022
Q4 		$1K Buy
+46
New +$1.24K ﹤0.01% 6413

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

JP Morgan Chase's IDNA Position: Q4 2024 in Review

JP Morgan Chase sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q4 2024, closing a stake of 583 shares — an estimated $14.3K sold.

JP Morgan Chase first reported a position in IDNA in Q4 2022 and held it in 6 quarters. The position peaked at $45.4K in Q2 2024. 58 funds tracked by Wall St. Rank hold IDNA as of Q4 2024.

  • JP Morgan Chase reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q4 2024 after selling out during the quarter.
  • JP Morgan Chase sold 583 iShares Genomics Immunology and Healthcare ETF shares in Q4 2024, an estimated $14.3K.
  • JP Morgan Chase first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2022 and held it in 6 quarters.
  • JP Morgan Chase's iShares Genomics Immunology and Healthcare ETF position peaked at $45.4K in Q2 2024.
  • 58 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q4 2024.

Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.